June 08, 2009
Article
Dennis Slamon, MD, PhD, discusses HER2 and the development of Herceptin.
Simple Ways for Patients With Cancer to Start Exercising
Finding Credible Voices in the Lynch Syndrome Community
Understanding Your Stage 2 Lymphoma Diagnosis
FDA Approves Revuforj for R/R NPM1-Mutant AML